Healthcare-associated infections in a department of urology: Incidence and patterns of antibiotic resistance

Scandinavian Journal of Urology

Volumn 48, Issue 2, 2014, Pages 203-209

  Medina Polo, José ^a   Jiménez Alcaide, Estíbaliz ^a   García González, Lucía ^a   Guerrero Ramos, Félix ^a   Pérez Cadavid, Santiago ^a   Arrébola Pajares, Ana ^a   Sopeña Sutil, Raquel ^a   Benítez Salas, Raúl ^a   Díaz González, Rafael ^a   Tejido Sánchez, Ángel ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Antibiotic resistance; Antibiotic use; Healthcare associated infection; Prevalence study; Surgical site infection; Urinary tract infection; Urology department; Venous associated infection

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS AMPICILLIN; AMPICILLIN; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOTAXIME PLUS CEFTRIAXONE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA; CATHETER INFECTION; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL DEPARTMENT; HUMAN; INCIDENCE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; OBSERVATIONAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS; SPAIN; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; VENOUS CATHETER ASSOCIATED BACTEREMIA;

AGED; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; FEMALE; HOSPITAL DEPARTMENTS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; UROLOGY;

EID: 84896109160     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/21681805.2013.834512     Document Type: Article

References (23)

1. Horan TC, Andrus A, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;5:309-32. (Pubitemid 351763841)
2. Wagenlehner FME, Naber KG. Treatment of bacterial urinary tract infections: presence and future. Eur Urol 2006;49: 235-44. (Pubitemid 43197859)
3. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182-205. (Pubitemid 15158531)
4. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44.
5. Wallace WC, Cinat ME, Nastanski F, Gornick WB, Wilson SE. New epidemiology for postoperative nosocomial infections. Am Surg 2000;66:874-8. (Pubitemid 30666937)
6. Bjerklund Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P. Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 2007;51:1100-11.
7. Bjerklund Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P. Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 2006;58:S91-107.
8. Monge Jodra V, Sanz Cuesta MT, Olalla García MT, Muñón Carpio MF. [Nosocomial infections in a urology department: temporal tendencies of the accumulated incidence during the period 1984-1988]. Rev Clin Esp 1991;189:309-13.
9. Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerging Infect Dis 2001;7:342-7. (Pubitemid 32374358)
10. Milan PB, Ivan IM. Catheter-associated and nosocomial urinary tract infections: antibiotic resistance and influence on commonly used antimicrobial therapy. Int Urol Nephrol 2009;41:461-4.
11. Oteo J, Pérez-Vázquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010;23: 320-6.
12. Olaechea PM, Insausti J, Blanco A, Luque P.[Epidemiology and impact of nosocomial infections]. Med Intensiva 2010; 34:256-67.
13. Sánchez-Payá J, Bischofberger C, Lizan M, Lozano J, Muñoz Platón E, Navarro J, et al. Nosocomial infection surveillance and control: current situation is Spanish hospitals. J Hosp Infect 2009;72:50-6.
14. Roselló-Urgell J, Vaqué-Rafart J, Hermosilla-Pérez E, Allepuz-Palau A. EPINE Working Group. An approach to the study of potentially preventable nosocomial infections. Infect Control Hosp Epidemiol 2004;25:41-6. (Pubitemid 38139844)
15. Ballestero Diego R, Rebollo Rodrigo H, Gutiérrez Baños JL, Aguilera Tubet C, Zubillaga Guerrero S. García Martín B. [Nosocomial infection and infection of the surgical site in a third level hospital (2002-2005)]. Actas Urol Esp 2006;30: 905-12.
16. DasGupta R, Sullivan R, French G, O'Brien T. Evidencebased prescription of antibiotics in urology: a 5-year review of microbiology. BJU Int 2009;104:760-4.
17. Díaz-Agero C, Pita-López MJ, Robustillo-Rodela A, Rodríguez-Caravaca G, Martínez-Mondejar B, Monge-Jodra V. [Incidence of nosocomial infection in open prostate surgery]. Actas Urol Esp 2011;35:266-71.
18. Wagenlehner FM, Cek M, Naber KG, Kiyota H, Bjerklund-Johansen TE. Epidemiology, treatment and prevention of healthcare-associated urinary tract infections. World J Urol 2012;30:57-67.
19. Wazait HD, Patel HR, Veer V, Kelsey M, Van Der Meulen JH, Miller RA, et al. Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996- 2001). BJU Int 2003;91:806-9. (Pubitemid 36724064)
20. Centers for Disease Control and Prevention (CDC) [Internet]. Retrieved 2013. Available from http://www.cdc.gov.
21. European Centre for Disease Prevention and Control (ECDC) [Internet]. Retrieved 2013 Available from http://ecdc.europa.eu/en/Pages/home.aspx.
22. Rubio-Pérez I, Martín-Pérez E, Domingo García D, López- Brea Calvo M, Larrañaga Barrera E. Extended-spectrum beta-lactamase-producing bacteria in a tertiary care hospital in Madrid: epidemiology, risk factors and antimicrobial susceptibility patterns. Emerg Health Threats J 2012;5:11589.
23. Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñóz et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibioticresistant strain and their impact on the outcome. J Antimicrob Chemother 2009;63:568-74.